Major or mild neurocognitive disorder due to Parkinson's disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:
==Major or Mild Neurocognitive Disorder Due to Parkinson's Disease==
==Major or Mild Neurocognitive Disorder Due to Parkinson's Disease==


===DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Parkinson's Disease<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>===
===DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Parkinson's Disease<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>===
{{cquote|
{{cquote|


Line 39: Line 39:
75,000 per 100,000 (75%) major neurocognitive disorder.
75,000 per 100,000 (75%) major neurocognitive disorder.


27,000 per 100,000 (27%) mild neurocognitive disorder.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>
27,000 per 100,000 (27%) mild neurocognitive disorder.<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>


==Risk Factors==
==Risk Factors==
*Herbicides
*Increasing duration of disease
*Older age at disease onset
*Pesticides<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>
==Differential Diagnosis==
==Differential Diagnosis==
*Major or mild neurocognitive disorder due to [[Alzheimer’s disease]]
*Major or mild neurocognitive disorder with [[Lewy bodies]]
*Major or mild vascular neurocognitive disorder
*Neurocognitive disorder due to another medical condition (e.g., neurodegenerative disorders)
:*Corticobasal degeneration
:*[[Hydrocephalus]]
:*Multiple system atrophy
:*[[Progressive supranuclear palsy]]
:*Tumors
*Neuroleptic-induced parkinsonism
*Other medical conditions
:*[[B12 deficiency]]
:*[[Delirium]]
:*[[Hypothyroidism]]
:*Impaired cognition
:*Side effects of dopamine-blocking drugs
:*Sedation<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 16:32, 3 May 2018

Parkinson's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Parkinson's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Neurocognitive Disorder Due to Parkinson's Disease

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Major or mild neurocognitive disorder due to Parkinson's disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Major or mild neurocognitive disorder due to Parkinson's disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Major or mild neurocognitive disorder due to Parkinson's disease

CDC on Major or mild neurocognitive disorder due to Parkinson's disease

Major or mild neurocognitive disorder due to Parkinson's disease in the news

Blogs on Major or mild neurocognitive disorder due to Parkinson's disease

Directions to Hospitals Treating Parkinson's disease

Risk calculators and risk factors for Major or mild neurocognitive disorder due to Parkinson's disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Major or Mild Neurocognitive Disorder Due to Parkinson's Disease

DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Parkinson's Disease[1]

  • A.The criteria are met for major or mild neurocognitive disorder.

AND

  • B.The disturbance occurs in the setting of established Parkinson’s disease.

AND

  • C.There is insidious onset and gradual progression of impairment.

AND

  • D.The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.

Major or mild neurocognitive disorder probably due to Parkinson’s disease should be diagnosed if 1 and 2 are both met. Major or mild neurocognitive disorder possibly due to Parkinson’s disease should be diagnosed if 1 or 2 is met:

  • 1.There is no evidence of mixed etiology (i.e., absence of other neurodegenerative or cerebrovascular disease or another neurological, mental, or systemic disease or condition

likely contributing to cognitive decline).

  • 2.The Parkinson’s disease clearly precedes the onset of the neurocognitive disorder.

Epidemiology and Demographics

Prevalence

The prevalence of major or mild neurocognitive disorder due to parkinson's disease is:

75,000 per 100,000 (75%) major neurocognitive disorder.

27,000 per 100,000 (27%) mild neurocognitive disorder.[1]

Risk Factors

Differential Diagnosis

References

  1. 1.0 1.1 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.